index	sentence	Gene	Mutation
0	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition	SLCO1B3	rs4149117
1	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition	SLCO1B3	rs7311358
2	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition	SLCO1B3	rs4793665
3	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition	SLCO1B3	rs11568591
4	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition	SLCO1B3	rs4149117
5	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition	SLCO1B3	rs7311358
6	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition	SLCO1B3	rs4793665
7	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition	SLCO1B3	rs11568591
8	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition	ABCC3	rs4149117
9	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition	ABCC3	rs4149117
10	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition	ABCC3	rs7311358
11	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition	ABCC3	rs7311358
12	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition	ABCC3	rs4793665
13	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition	ABCC3	rs11568591
14	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition	ABCC3	rs4793665
15	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition	ABCC3	rs11568591
16	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	SLCO1B3	rs4149117
17	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	SLCO1B3	G>T in exon 3
18	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	SLCO1B3	112Ser>Ala
19	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	SLCO1B3	rs7311358
20	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	SLCO1B3	A>G in exon 6
21	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	SLCO1B3	rs4149117
22	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	SLCO1B3	G>T in exon 3
23	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	SLCO1B3	112Ser>Ala
24	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	SLCO1B3	rs7311358
25	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	SLCO1B3	A>G in exon 6
26	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	OATP1B3	rs4149117
27	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	OATP1B3	G>T in exon 3
28	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	OATP1B3	112Ser>Ala
29	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	OATP1B3	rs7311358
30	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	OATP1B3	A>G in exon 6
31	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	OATP1B3	rs4149117
32	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	OATP1B3	G>T in exon 3
33	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	OATP1B3	112Ser>Ala
34	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	OATP1B3	rs7311358
35	Two common single-nucleotide polymorphisms (SNPs) within SLCO1B3, affecting the OATP1B3 amino acid sequence, were described: rs4149117:G>T in exon 3, resulting in 112Ser>Ala change, and rs7311358:A>G in exon 6, leading to 233Met>Ile amino acid substitution	OATP1B3	A>G in exon 6
36	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	ABCC3	rs4793665
37	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	ABCC3	T>C in position -211
38	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	ABCC3	rs11568591
39	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	ABCC3	G>A in exon 27
40	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	ABCC3	1297Arg>His
41	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	ABCC3	rs4793665
42	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	ABCC3	T>C in position -211
43	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	ABCC3	rs11568591
44	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	ABCC3	G>A in exon 27
45	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	ABCC3	1297Arg>His
46	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	MRP3	rs4793665
47	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	MRP3	rs4793665
48	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	MRP3	T>C in position -211
49	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	MRP3	T>C in position -211
50	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	MRP3	rs11568591
51	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	MRP3	G>A in exon 27
52	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	MRP3	1297Arg>His
53	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	MRP3	rs11568591
54	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	MRP3	G>A in exon 27
55	A common promoter polymorphism was described in ABCC3 gene (rs4793665:T>C in position -211) and associated with altered hepatic MRP3 mRNA expression, whereas among SNPs altering amino acid sequence, rs11568591:G>A in exon 27 (1297Arg>His) appears with relatively high frequency in Caucasians.	MRP3	1297Arg>His
56	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition.	SLCO1B3	rs4149117
57	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition.	SLCO1B3	rs7311358
58	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition.	SLCO1B3	rs4793665
59	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition.	SLCO1B3	rs11568591
60	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition.	SLCO1B3	rs4149117
61	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition.	SLCO1B3	rs7311358
62	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition.	SLCO1B3	rs4793665
63	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition.	SLCO1B3	rs11568591
64	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition.	ABCC3	rs4149117
65	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition.	ABCC3	rs4149117
66	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition.	ABCC3	rs7311358
67	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition.	ABCC3	rs7311358
68	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition.	ABCC3	rs4793665
69	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition.	ABCC3	rs11568591
70	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition.	ABCC3	rs4793665
71	The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition.	ABCC3	rs11568591
72	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	rs4793665
73	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	C>T in position -211
74	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	rs11568591
75	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	G>A in exon 27
76	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	1297Arg>His
77	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	rs4149117
78	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	T>G in exon 3
79	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	rs7311358
80	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	G>A in exon 6
81	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	rs4793665
82	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	C>T in position -211
83	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	rs11568591
84	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	G>A in exon 27
85	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	1297Arg>His
86	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	rs4149117
87	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	T>G in exon 3
88	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	rs7311358
89	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	ABCC3	G>A in exon 6
90	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	rs4793665
91	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	rs4793665
92	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	C>T in position -211
93	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	C>T in position -211
94	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	rs11568591
95	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	rs11568591
96	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	G>A in exon 27
97	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	G>A in exon 27
98	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	1297Arg>His
99	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	1297Arg>His
100	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	rs4149117
101	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	T>G in exon 3
102	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	rs7311358
103	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	G>A in exon 6
104	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	rs4149117
105	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	T>G in exon 3
106	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	rs7311358
107	Patients were genotyped for the presence of two functional SNPs in ABCC3 gene (rs4793665:C>T in position -211 of promoter sequence, and rs11568591:G>A in exon 27, resulting in 1297Arg>His amino acid substitution) and two SNPs in SLCO1B3 (rs4149117:T>G in exon 3 -112Ser>Ala, and rs7311358:G>A in exon 6 -233Met>Ile)	SLCO1B3	G>A in exon 6
108	The distribution of all analyzed SNPs, i.e., rs4793665:C>T and rs11568591:G>A in ABCC3 as well as rs4149117:T>G and rs7311358:G>A in SLCO1B3, was in concordance with Hardy-Weinberg equilibrium	ABCC3	rs4793665
109	The distribution of all analyzed SNPs, i.e., rs4793665:C>T and rs11568591:G>A in ABCC3 as well as rs4149117:T>G and rs7311358:G>A in SLCO1B3, was in concordance with Hardy-Weinberg equilibrium	ABCC3	rs4793665
110	The distribution of all analyzed SNPs, i.e., rs4793665:C>T and rs11568591:G>A in ABCC3 as well as rs4149117:T>G and rs7311358:G>A in SLCO1B3, was in concordance with Hardy-Weinberg equilibrium	SLCO1B3	rs4793665
111	The distribution of all analyzed SNPs, i.e., rs4793665:C>T and rs11568591:G>A in ABCC3 as well as rs4149117:T>G and rs7311358:G>A in SLCO1B3, was in concordance with Hardy-Weinberg equilibrium	SLCO1B3	rs4793665
112	The distribution of all analyzed SNPs, i.e., rs4793665:C>T and rs11568591:G>A in ABCC3 as well as rs4149117:T>G and rs7311358:G>A in SLCO1B3, was in concordance with Hardy-Weinberg equilibrium	ABCC3	rs11568591
113	The distribution of all analyzed SNPs, i.e., rs4793665:C>T and rs11568591:G>A in ABCC3 as well as rs4149117:T>G and rs7311358:G>A in SLCO1B3, was in concordance with Hardy-Weinberg equilibrium	ABCC3	rs11568591
114	The distribution of all analyzed SNPs, i.e., rs4793665:C>T and rs11568591:G>A in ABCC3 as well as rs4149117:T>G and rs7311358:G>A in SLCO1B3, was in concordance with Hardy-Weinberg equilibrium	SLCO1B3	rs11568591
115	The distribution of all analyzed SNPs, i.e., rs4793665:C>T and rs11568591:G>A in ABCC3 as well as rs4149117:T>G and rs7311358:G>A in SLCO1B3, was in concordance with Hardy-Weinberg equilibrium	SLCO1B3	rs11568591
116	The distribution of all analyzed SNPs, i.e., rs4793665:C>T and rs11568591:G>A in ABCC3 as well as rs4149117:T>G and rs7311358:G>A in SLCO1B3, was in concordance with Hardy-Weinberg equilibrium	ABCC3	rs4149117
117	The distribution of all analyzed SNPs, i.e., rs4793665:C>T and rs11568591:G>A in ABCC3 as well as rs4149117:T>G and rs7311358:G>A in SLCO1B3, was in concordance with Hardy-Weinberg equilibrium	ABCC3	rs7311358
118	The distribution of all analyzed SNPs, i.e., rs4793665:C>T and rs11568591:G>A in ABCC3 as well as rs4149117:T>G and rs7311358:G>A in SLCO1B3, was in concordance with Hardy-Weinberg equilibrium	ABCC3	rs4149117
119	The distribution of all analyzed SNPs, i.e., rs4793665:C>T and rs11568591:G>A in ABCC3 as well as rs4149117:T>G and rs7311358:G>A in SLCO1B3, was in concordance with Hardy-Weinberg equilibrium	ABCC3	rs7311358
120	The distribution of all analyzed SNPs, i.e., rs4793665:C>T and rs11568591:G>A in ABCC3 as well as rs4149117:T>G and rs7311358:G>A in SLCO1B3, was in concordance with Hardy-Weinberg equilibrium	SLCO1B3	rs4149117
121	The distribution of all analyzed SNPs, i.e., rs4793665:C>T and rs11568591:G>A in ABCC3 as well as rs4149117:T>G and rs7311358:G>A in SLCO1B3, was in concordance with Hardy-Weinberg equilibrium	SLCO1B3	rs4149117
122	The distribution of all analyzed SNPs, i.e., rs4793665:C>T and rs11568591:G>A in ABCC3 as well as rs4149117:T>G and rs7311358:G>A in SLCO1B3, was in concordance with Hardy-Weinberg equilibrium	SLCO1B3	rs7311358
123	The distribution of all analyzed SNPs, i.e., rs4793665:C>T and rs11568591:G>A in ABCC3 as well as rs4149117:T>G and rs7311358:G>A in SLCO1B3, was in concordance with Hardy-Weinberg equilibrium	SLCO1B3	rs7311358
124	in relation to SLCO1B1 c.388G>A SNP that had been associated with altered plasma concentrations of bile acids.	SLCO1B1	c.388G>A
125	in relation to SLCO1B1 c.388G>A SNP that had been associated with altered plasma concentrations of bile acids.	SLCO1B1	c.388G>A
126	ABCC3 gene rs4793665 polymorphism is located at position -211 in the promoter region of the gene	ABCC3	rs4793665
127	ABCC3 gene rs4793665 polymorphism is located at position -211 in the promoter region of the gene	ABCC3	rs4793665
128	The ABCC3 gene rs4793665 polymorphism was significantly associated with methotrexate pharmacokinetics both in juvenile idiopathic arthritis and in pediatric osteosarcoma patients.	ABCC3	rs4793665
129	The ABCC3 gene rs4793665 polymorphism was significantly associated with methotrexate pharmacokinetics both in juvenile idiopathic arthritis and in pediatric osteosarcoma patients.	ABCC3	rs4793665
130	The SLCO1B3 gene rs4149117 and rs7311358 polymorphisms have been shown to affect the efficacy of statin treatment in patients with hypercholesterolemia	SLCO1B3	rs4149117
131	The SLCO1B3 gene rs4149117 and rs7311358 polymorphisms have been shown to affect the efficacy of statin treatment in patients with hypercholesterolemia	SLCO1B3	rs7311358
132	The SLCO1B3 gene rs4149117 and rs7311358 polymorphisms have been shown to affect the efficacy of statin treatment in patients with hypercholesterolemia	SLCO1B3	rs4149117
133	The SLCO1B3 gene rs4149117 and rs7311358 polymorphisms have been shown to affect the efficacy of statin treatment in patients with hypercholesterolemia	SLCO1B3	rs7311358
134	Identification and functional characterization of the natural variant MRP3-Arg1297 His of human multidrug resistance protein 3 (MRP3/ABCC3)	MRP3	Arg1297 His
135	Identification and functional characterization of the natural variant MRP3-Arg1297 His of human multidrug resistance protein 3 (MRP3/ABCC3)	MRP3	Arg1297 His
136	Identification and functional characterization of the natural variant MRP3-Arg1297 His of human multidrug resistance protein 3 (MRP3/ABCC3)	multidrug resistance protein 3	Arg1297 His
137	Identification and functional characterization of the natural variant MRP3-Arg1297 His of human multidrug resistance protein 3 (MRP3/ABCC3)	multidrug resistance protein 3	Arg1297 His
138	Identification and functional characterization of the natural variant MRP3-Arg1297 His of human multidrug resistance protein 3 (MRP3/ABCC3)	MRP3	Arg1297 His
139	Identification and functional characterization of the natural variant MRP3-Arg1297 His of human multidrug resistance protein 3 (MRP3/ABCC3)	MRP3	Arg1297 His
140	Identification and functional characterization of the natural variant MRP3-Arg1297 His of human multidrug resistance protein 3 (MRP3/ABCC3)	ABCC3	Arg1297 His
141	Identification and functional characterization of the natural variant MRP3-Arg1297 His of human multidrug resistance protein 3 (MRP3/ABCC3)	ABCC3	Arg1297 His
142	Organic anion transporter protein (OATP1B1) encoded by SLCO1B1 gene polymorphism (388A>G) & susceptibility in gallstone disease	OATP1B1	388A>G
143	Organic anion transporter protein (OATP1B1) encoded by SLCO1B1 gene polymorphism (388A>G) & susceptibility in gallstone disease	OATP1B1	388A>G
144	Organic anion transporter protein (OATP1B1) encoded by SLCO1B1 gene polymorphism (388A>G) & susceptibility in gallstone disease	SLCO1B1	388A>G
145	Organic anion transporter protein (OATP1B1) encoded by SLCO1B1 gene polymorphism (388A>G) & susceptibility in gallstone disease	SLCO1B1	388A>G
146	Cholesterol 7alpha-hydrolase (CYP7A1) c.-278A>C promoter polymorphism in gallstone disease patients	CYP7A1	c.-278A>C
147	Cholesterol 7alpha-hydrolase (CYP7A1) c.-278A>C promoter polymorphism in gallstone disease patients	CYP7A1	c.-278A>C
